Clinical Scorecard: Profiles of Clinical, Metabolomic, and Proteomic Factors Linked to Reproductive Outcomes in Cases of Unexplained Recurrent Pregnancy Loss
At a Glance
Category
Detail
Condition
Unexplained Recurrent Pregnancy Loss (URPL)
Key Mechanisms
Hormonal and metabolic factors influencing conception and early pregnancy maintenance.
Target Population
Women aged 18 to 45 years with a history of unexplained recurrent pregnancy loss.
Care Setting
Reproductive Immunology Clinic
Key Highlights
66.4% of women with URPL conceived during the follow-up period.
Higher testosterone levels were associated with lower probability of conception.
Among women who conceived, higher prolactin levels correlated with increased odds of early pregnancy loss.
Lower bile acid-related metabolites were observed in cases of early pregnancy loss.
7α,12α-dihydroxy-3-oxocholest-4-en-27-oic acid was identified as a candidate metabolomic factor associated with reproductive outcomes.
Guideline-Based Recommendations
Diagnosis
Evaluate established causes of recurrent pregnancy loss, including genetic and anatomical factors.
Management
Consider hormonal and metabolic factors in the management of URPL.
Monitoring & Follow-up
Monitor hormonal levels, including testosterone and prolactin, in women with URPL.
Risks
Higher testosterone and prolactin levels may indicate risks for conception and early pregnancy loss.
Patient & Prescribing Data
Women with unexplained recurrent pregnancy loss seeking conception.
Empiric therapeutic interventions may be driven by limited prognostic discrimination.
Clinical Best Practices
Utilize multi-omics profiling to assess biological complexity in URPL.
Conduct prospective studies to evaluate baseline clinical characteristics before conception.
